Newsroom

The People Who Brought You Cheaper Hepatitis C Drugs Are Going After Cancer Next

Express Scripts, which this year forced price concessions from makers of $1,000-a-day hepatitis C medicines, has set its sights on $37 billion in U.S. spending on cancer medications.

Read more

High Prices for Cancer Drugs are set at Launch: ‘It’s Where the Action Is’

There is little question that rising prices for medicines – including many cancer treatments – is a flashpoint in the growing controversy over health care costs.

Read more

State could help Fresno-area hepatitis C sufferers afford costly drugs

Just weeks into a new drug treatment for hepatitis C, Travis Poole felt like getting out of bed and going back to work as a painting […]

Read more

Specialty drugs and health care costs

As the year came to a close, many employers were reviewing 2014 expenses to help plan spending for the new year.

Read more